Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Heliyon ; 10(11): e32027, 2024 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-38868037

RESUMEN

Objective: Understanding the characteristics of alveolar bone resorption in an East Asian population after maxillary incisor extraction and providing a reference for implant treatment plans. Study design: Cone-beam computerized tomography (CBCT) data of 125 East Asian patients with unilateral extraction of maxillary incisors for 3 months were collected. The alveolar bone width and height in the extraction sites were measured and compared with the corresponding contralateral sites. Results: The differences in alveolar bone width between the extraction site and contralateral site were as follows: 4.11 mm, 2.68 mm, and 2.09 mm (3 mm, 5 mm, 7 mm apical from CEJ of the contralateral tooth). Data are expressed as the median. The horizontal resorption ratio of alveolar bone was 49.94 %, 31.5 %, and 24.46 %. The difference in alveolar bone height was 0.78 mm. The vertical resorption ratio was 7.78 %. The resorption did not differ significantly between sexes and was not significantly affected by tooth positions. Conclusions: In the studied East Asian population, significant horizontal and vertical alveolar bone resorption occurs after natural healing of maxillary incisor extraction for 3 months. The closer to the alveolar ridge crest, the more significant the horizontal resorption, resulting in an "inverted triangle" shape residual alveolar bone.

2.
Nanotechnology ; 24(32): 325101, 2013 Aug 16.
Artículo en Inglés | MEDLINE | ID: mdl-23867977

RESUMEN

Multifunctional liposomes loaded with quantum dots (QDs) and anticancer drugs were prepared for simultaneous bioimaging and drug delivery. Different formulations, including cationic, PEGylated and deformable liposomes, were compared for their theranostic efficiency. We had evaluated the physicochemical characteristics of these liposomes. The developed liposomes were examined using experimental platforms of cytotoxicity, cell migration, cellular uptake, in vivo melanoma imaging and drug accumulation in tumors. The average size of various nanocomposite liposomes was found to be 92­134 nm. Transmission electron microscopy confirmed the presence of QDs within liposomal bilayers. The incorporation of polyethylene glycol (PEG) and Span 20 into the liposomes greatly increased the fluidity of the bilayers. The liposomes provided sustained release of camptothecin and irinotecan. The cytotoxicity and cell migration assay demonstrated superior activity of cationic liposomes compared with other carriers. Cationic liposomes also showed a significant fluorescence signal in melanoma cells after internalization. The liposomes were intratumorally administered to a melanoma-bearing mouse. Cationic liposomes showed the brightest fluorescence in tumors, followed by classical liposomes. This signal could last for up to 24 h for cationic nanosystems. Intratumoral accumulation of camptothecin from free control was 35 nmol g(−1); it could be increased to 50 nmol g(−1) after loading with cationic liposomes. However, encapsulation of irinotecan into liposomes did not further increase intratumoral drug accumulation. Cationic liposomes were preferable to other liposomes as nanocarriers in both bioimaging and therapeutic approaches.


Asunto(s)
Antineoplásicos/farmacología , Diagnóstico por Imagen/métodos , Sistemas de Liberación de Medicamentos , Liposomas , Nanocompuestos , Polietilenglicoles/química , Puntos Cuánticos , Animales , Rastreo Diferencial de Calorimetría , Camptotecina/análogos & derivados , Camptotecina/farmacología , Cationes , Supervivencia Celular/efectos de los fármacos , Femenino , Irinotecán , Melanoma Experimental , Ratones , Ratones Desnudos , Nanocompuestos/ultraestructura , Tamaño de la Partícula , Fosfatidilcolinas/metabolismo , Espectrometría de Fluorescencia , Electricidad Estática , Cicatrización de Heridas/efectos de los fármacos
3.
Nanomedicine (Lond) ; 8(8): 1253-69, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23384703

RESUMEN

AIM: The authors studied the bioimaging and delivery of drug-entrapped, nanostructured lipid carriers with quantum dots (QDs), called QDNLCs, for integrating imaging and therapy. MATERIALS & METHODS: Nanostructured lipid carriers consisting of QDs, including lipophilic QDs, carboxyl-function QDs or PEG QDs were prepared. Application of the nanocarriers was evaluated by cytotoxicity, cell migration, cellular uptake, in vivo real-time tumor monitoring and drug accumulation in tumors. RESULTS: All QDNLCs exhibited a size of 245 nm with camptothecin encapsulation of >99%. Cytotoxicity of the nanoparticles against melanoma cells was superior to that of free camptothecin. Carboxylic acid-conjugated QDNLCs (C-QDNLCs) showed the highest cell internalization and in vivo fluorescence labeling compared with the other carriers. Real-time bioimaging demonstrated that C-QDNLCs maintained signaling in tumors for at least 24 h. The camptothecin accumulation in melanomas increased by 6.4-fold after incorporation into C-QDNLCs. CONCLUSION: For the first time, nanostructured lipid carriers were coordinated with QDs and an anticancer drug to provide efficient tumor imaging and drug delivery. Original submitted 1 May 2012; Revised submitted 30 August 2012; Published online 5 February 2013.


Asunto(s)
Diagnóstico por Imagen/métodos , Lípidos/química , Nanoestructuras/administración & dosificación , Neoplasias/tratamiento farmacológico , Antineoplásicos , Camptotecina/administración & dosificación , Camptotecina/química , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Portadores de Fármacos/administración & dosificación , Portadores de Fármacos/química , Humanos , Lípidos/administración & dosificación , Nanoestructuras/química , Neoplasias/diagnóstico , Neoplasias/patología , Polietilenglicoles/administración & dosificación , Polietilenglicoles/química , Puntos Cuánticos/administración & dosificación , Puntos Cuánticos/química
4.
Cardiovasc Intervent Radiol ; 35(6): 1460-6, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22367009

RESUMEN

PURPOSE: To evaluate the effects of left gastric artery embolization (LGAE) on plasma ghrelin levels, abdominal fat, and body weight in beagles. METHODS: The institutional animal care and use committee approved this study. Fifteen healthy adult beagles (12 male and three female animals) were randomly divided into three experimental groups: LGAE was proceeded with mixed emulsion of bleomycin A(5) hydrochloride and lipiodol (group A), and polyvinyl alcohol particles (group B). Transcatheter saline injections in the left gastric artery were performed as a control. Weight and fasting plasma ghrelin levels were obtained at baseline and at weekly intervals for 8 weeks after the procedure in all animals. All animals were scanned and measured by multidetector computed tomography at baseline and at week 8 for evaluation of abdominal fat. RESULTS: In LGAE-treated animals, plasma ghrelin and body weight significantly decreased compared to control animals (group A: P = 0.007 and P = 0.000; group B: P = 0.004 and P = 0.000, respectively). Subcutaneous fat size was also significantly reduced (P = 0.011 and P = 0.027 for groups A and B, respectively). The decreasing percentage in ghrelin levels at week 6 (peak of recovery) of LGAE-treated animals were negatively correlated with the size of area supplied by left gastric artery (r = -0.693, P = 0.026). CONCLUSION: LGAE could suppress the plasma concentration of ghrelin, which results in subcutaneous fat size reduction and weight loss. Compensatory ghrelin production might occur in the remnant gastric fundus after LGAE.


Asunto(s)
Grasa Abdominal/efectos de los fármacos , Embolización Terapéutica , Ghrelina/sangre , Estómago/irrigación sanguínea , Pérdida de Peso/efectos de los fármacos , Grasa Abdominal/diagnóstico por imagen , Análisis de Varianza , Angiografía de Substracción Digital , Animales , Bleomicina/farmacología , Perros , Aceite Etiodizado/farmacología , Alcohol Polivinílico/farmacología , Distribución Aleatoria , Tomografía Computarizada por Rayos X
5.
Clin Chim Acta ; 411(17-18): 1218-22, 2010 Sep 06.
Artículo en Inglés | MEDLINE | ID: mdl-20438722

RESUMEN

BACKGROUND: 8-Oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodGuo) is the most frequently measured biomarker of oxidative stress. Chromatographic-based methods for 8-oxodGuo in urine are well established; however, the 8-oxodGuo measurement in plasma and saliva has been problematic. METHODS: We firstly and successfully applied an on-line solid-phase extraction (SPE) LC-MS/MS following manual SPE pretreatment to quantify the 8-oxodGuo both in plasma and saliva. Urine, plasma and saliva specimens were simultaneously collected from 50 healthy adults and measured for 8-oxodGuo. RESULTS: Mean baseline levels of 8-oxodGuo in plasma and saliva were 21.7+/-9.2 and 5.1+/-2.6pg/ml, respectively, being far lower than that in urine (6.2+/-4.8ng/ml). The 8-oxodGuo levels obtained in this study for plasma and saliva were, however, up to several hundred times lower than those reported by commercial ELISA kit in the literature. Furthermore, the 8-oxodGuo levels in plasma and saliva were significantly correlated with the 8-oxodGuo levels in urine (Spearman correlation coefficients, r=0.33, P=0.02 for plasma and r=0.56, P=0.0015 for saliva). 8-OxodGuo in plasma was also correlated with the 8-oxodGuo in saliva (r=0.52, P=0.0041). CONCLUSIONS: Significantly correlations were observed between plasma, saliva and urine, giving the possibility of using other body fluids in addition to urine for assessing whole body oxidative stress.


Asunto(s)
Desoxiguanosina/análogos & derivados , Saliva/metabolismo , 8-Hidroxi-2'-Desoxicoguanosina , Adolescente , Adulto , Cromatografía Liquida , Desoxiguanosina/análisis , Desoxiguanosina/sangre , Desoxiguanosina/orina , Humanos , Espectrometría de Masas en Tándem
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA